Financial News
Bayer Aktienges ADR (OP: BAYRY )
7.810
+0.130
(+1.69%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Bayer Aktienges ADR
![](https://cdn.benzinga.com/files/images/story/2023/07/31/regn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/17/screenshot_2023-07-17_at_5.33.51_pm.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/29/azn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/28/aapharma_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/Parkinsons_disease_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2017/11/23/06/19/flag-2972108_1280.jpg)
![](https://cdn.pixabay.com/photo/2017/11/23/06/19/flag-2972108__480.jpg)
![](https://www.investors.com/wp-content/uploads/2020/08/Stock-regeneron-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Standouts.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/23/fusn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/08/prgo_1.png?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2023/04/24/tylenol.png?width=1200&height=800&fit=crop)
![](https://talkmarkets.comhttp://www.picpedia.org/clipboard/images/mergers-and-acquisitions.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/nato_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/mrk.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2023/03/10/aapharma.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/14/sean_samuel_cannabis_janon_stock_on_shutterstock_and_photo_courtesy_of_sean_samuel_vp_sales__marketing_-_c15_solutions_inc..jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/01/Stock-bayerbuilding-01-adobe.jpg)
![](https://images.mauldineconomics.com/uploads/newsletters/Chart_1_20230123_SMM.png)
![](https://cdn.benzinga.com/files/images/story/2023/01/18/bayer_cross_in_leverkusen_at_nightdefault.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/11/airplane_grounded-shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/11/bayer_ag_cross_2005.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/19/cannabis_shacking_hands_lindsayfox_and_tusumi_by_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/04/ions_logo_light__a1a3db690556ba7e6b07c28b193b235b.png?width=1200&height=800&fit=crop)
Ionis Regains Rights To Thrombosis Candidate From Bayer
November 04, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.